Surgery Partners

Last year was a pivotal year for the ambulatory surgery center (ASC) industry, marked by transformative trends, groundbreaking innovations and high-stakes decisions that reshaped the landscape. It was also an exciting year for us at Ambulatory Surgery Center News, as we launched in the summer of 2024 with a mission to deliver in-depth reporting and actionable insights tailored to ASC operators, investors, payers, clinicians and other stakeholders. Since our debut, we've brought you stories … [Read more...]

GLP-1s and Medicare Advantage (MA) are two potential headwinds for ambulatory surgery centers (ASCs), with each undoubtedly playing a larger role in 2025. Partly because of this increasingly prominent standing, the U.S. Centers for Medicare & Medicaid Service (CMS) proposed new policies related to both GLP-1s, or glucagon-like peptide-1s, and MA on Nov. 26. “This proposed rule includes more policies to remove unnecessary barriers to care stemming from the use of inappropriate prior … [Read more...]

You can often take the pulse of any industry by analyzing the words of its leaders. And while there were plenty of interesting quotes from ambulatory surgery center (ASC) leaders in our reporting this year, a few stood out for their thoughtfulness, candor and relevance. From pricing transparency and strategic partnerships, to navigating compliance and the growing shift towards high-acuity procedures, these quotes capture the essence of the challenges and opportunities facing ASCs … [Read more...]

Executives with Surgery Partners (Nasdaq: SGRY) conveyed a bullish message on the potential for growth and remained quiet on the rumors of a potential company sale during Tuesday’s Q3 2024 earnings call. High-acuity procedures and strategic acquisitions are, and will continue to be, core drivers of growth, the leaders said. “Transition into the ASC setting – that shift in site of care – is in the early innings, and we are well-positioned, with our recruiting team and our portfolio of … [Read more...]

The Federal Reserve’s recent decision to cut interest rates by half a percentage point marks a shift in monetary policy, signaling that inflation is cooling and that the central bank may now be focused on keeping the labor market stable.  In turn, that could mean there’s more ambulatory surgery center (ASC) transaction activity on the horizon. “We’re trying to achieve a situation where we restore price stability without the kind of painful increase in unemployment that has come sometimes … [Read more...]

TPG Inc. (Nasdaq: TPG) and UnitedHealth Group (NYSE: UNH) have emerged as potential suitors for ambulatory surgery center (ASC) operating company Surgery Partners (Nasdaq: SGRY). UnitedHealth Group is the parent company of both UnitedHealthcare and Optum, its health care services arm. The health care giant is no stranger to the ASC space, with Optum taking over SCA Health for $2.3 billion in 2017. Meanwhile, TPG is a global alternative asset manager with $229 billion in assets under … [Read more...]

Surgery Partners Inc. (Nasdaq: SGRY) continues to benefit from the shift toward higher-acuity procedures being performed in lower-cost outpatient settings and surgical technology advancements. The increased demand for services linked to America’s rapidly aging population is likewise driving growth for the ambulatory surgery center (ASC) operator. “We expect that March [toward higher-acuity procedures] to continue,” Surgery Partners CEO Eric Evans said Tuesday during the company’s Q2 2024 … [Read more...]

Surgery Partners (Nasdaq: SGRY) is rumored to be exploring strategic alternatives, including a potential sale. But that doesn’t mean it’s coming out of acquisition mode. According to a post from legal firm Husch Blackwell, Surgery Partners recently worked with the Orthopedic Institute of Wisconsin to acquire 14 Wisconsin-based practice groups and two ambulatory surgery centers (ASCs). “Partners Tom Shorter and Jack Enea led the deal, which brings broad network access and value to patients … [Read more...]

One of the largest ambulatory surgery center (ASC) chains in the U.S. could be up for grabs. After seeing its stock price tumble throughout 2024, Surgery Partners (Nasdaq: SGRY) is now exploring strategic alternatives for the business, including a potential sale, according to a new report from Bloomberg. The ASC company has already engaged a financial adviser to gauge buyout interest, Bloomberg reported, citing people familiar with the matter. Founded in 2004, the Brentwood, … [Read more...]